Selective and effective cytotoxicity of folic acid-conjugated cholesteryl pullulan hydrogel nanoparticles complexed with doxorubicin in in vitro and in vivo studies

被引:13
作者
Hidaka, Masaaki
Kanematsu, Takashi
Ushio, Kazutoshi
Sunamoto, Junzo
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Transpalantat & Digest Surg, Nagasaki 8528102, Japan
[2] Niihama Natl Coll Technol, Dept Appl Chem & Biotechnol, Niihama, Japan
[3] Kyoto Univ, Nagasaki 8528102, Japan
关键词
folate receptor; drug targeting; cholesteryl pullulan; doxorubicin;
D O I
10.1177/0883911506069871
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
We previously reported that cholesteryl pullulan (CHP) derivatives were effective carriers drug delivery systems in targeting cancer cells. We have now synthesized folic acid-conjugated CHP hydrogel nanoparticles (FA-CHP). FA-CHP complexed with the anticancer drug doxorubicin (DOX) show a higher cytotoxicity than CHP complexed with DOX in in vitro studies. The expression of a folate receptor (FR) is elevated in many cancers; in this case, confocal image analysis revealed that FA-CHP complexed with DOX exhibited greater cellular uptake than CHP complexed with DOX in human epidermal carcinoma (KB) cells over-expressing surface FR. In vivo studies showed that the increase of tumor volume in a nude mice xenograft model was significantly suppressed. Accordingly, FA-CHP may be an effective vehicle for the delivery of anticancer drugs and has a potential application in the treatment of overexpressing FR solid tumor cells.
引用
收藏
页码:591 / 602
页数:12
相关论文
共 21 条
[1]
Akiyoshi K., 1996, SUPRAMOL SCI, V3, P157, DOI [10.1016/0968-5677(96)00031-4, DOI 10.1016/0968-5677(96)00031-4]
[2]
Folate receptors [J].
Antony, AC .
ANNUAL REVIEW OF NUTRITION, 1996, 16 :501-521
[3]
The α folate receptor is highly activated in malignant pleural mesothelioma [J].
Bueno, R ;
Appasani, K ;
Mercer, H ;
Lester, S ;
Sugarbaker, D .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (02) :225-233
[4]
Gu XG, 1998, CANCER RES, V58, P3385
[5]
CELL FRACTIONATION AND ELECTRON-MICROSCOPE STUDIES OF KIDNEY FOLATE-BINDING PROTEIN [J].
HJELLE, JT ;
CHRISTENSEN, EI ;
CARONE, FA ;
SELHUB, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (02) :C338-C346
[6]
Ichinose K, 1998, ANTICANCER RES, V18, P401
[7]
Polymeric micelles as new drug carriers [J].
Kwon, GS ;
Okano, T .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 21 (02) :107-116
[8]
Folate-mediated targeting: from diagnostics to drug and gene delivery [J].
Leamon, CP ;
Low, PS .
DRUG DISCOVERY TODAY, 2001, 6 (01) :44-51
[9]
LEE RJ, 1994, J BIOL CHEM, V269, P3198
[10]
The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting [J].
Maeda, H .
ADVANCES IN ENZYME REGULATION, VOL 41, 2001, 41 :189-207